Related Experiment Video
Updated: Aug 8, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Late in-stent thrombosis following carotid angioplasty and stenting
Jan-Hendrik Buhk1, Andreas Wellmer, Michael Knauth
1Department of Neuroradiology, University of Goettingen, Goettingen, Germany. jh.buhk@med.uni-goettingen.de
Insights
Delayed in-stent thrombosis after carotid angioplasty and stenting (CAS) can occur when antiplatelet therapy is stopped for other medical conditions. This complication highlights the importance of maintaining antiplatelet treatment post-CAS.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Interventional Cardiology
Background:
- Carotid angioplasty and stenting (CAS) is a procedure to open blocked carotid arteries.
- Acute in-stent thrombosis (IS T) is a serious complication following CAS.
- IS T is often linked to inadequate antiplatelet therapy.
Observation:
- The study presents three cases of delayed IS T.
- These events occurred between one week and three months post-CAS.
- In all cases, antiplatelet medication was temporarily discontinued.
Findings:
- Discontinuation of antiplatelet agents to manage comorbidities was associated with delayed IS T.
- Delayed IS T represents a specific risk profile in CAS patients.
- The timing of IS T can vary significantly after the procedure.
Implications:
- Careful consideration of antiplatelet therapy management is crucial in CAS patients with comorbidities.
- Strategies to mitigate IS T risk during temporary antiplatelet cessation are needed.
- This underscores the critical role of antiplatelet therapy in preventing IS T after CAS.
Abstract:
Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents. The authors report three cases of a delayed in-stent thrombosis after more than a week but less than 3 months after CAS. In all cases, the postprocedural antiplatelet regimen was discontinued to enable the treatment of a relevant comorbidity.
Related Concept Videos
Transient Ischemic Attack l: Introduction
Angina II: Classification
Acute Coronary Syndrome I: Introduction
Ischemic Stroke l: Introduction
Coronary Artery Disease V: Interprofessional Care
Ischemic Stroke ll: Pathophysiology